Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. [electronic resource]
Producer: 19841010Description: 469-77 p. digitalISSN:- 0003-4819
- Adult
- Aged
- Bacterial Infections -- drug therapy
- Cefotaxime -- adverse effects
- Clinical Trials as Topic
- Double-Blind Method
- Drug Therapy, Combination
- Enterobacter
- Enterobacteriaceae Infections -- drug therapy
- Escherichia coli Infections -- drug therapy
- Female
- Humans
- Infusions, Parenteral
- Kidney Diseases -- chemically induced
- Male
- Middle Aged
- Nafcillin -- administration & dosage
- Penicillin Resistance
- Prognosis
- Pseudomonas Infections -- drug therapy
- Random Allocation
- Tobramycin -- administration & dosage
- Urinary Tract Infections -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.